4Hopwood P, stephens RJ. Depression in patients with lung cancer: prevalence and risk factors derived from quality of life data. J Clin Oncol,2000,18(4) :893-903.
5Andrews G,Sanderson K,Slade T,et al. Why does the burden of diease persist? Relating the burden of anxiety and depression to effectiveness of treatment. Bull Word health Organ ,2000,78 (4) :454 - 466.
4Linos A, Riza E. Comparisons of cervical cancer screening programmes in the European Union[J]. EJC, 2000, 36:2260-2265.
5Bos AB,Van Ballegooijen M,Van Oortmarssen GJ, et al.Women who participate in spontaneous screening are not at higher risk for cervical cancer than women who attend programme screening[J]. EJC, 2002, 38: 827-831.
6Franceschi S, Herrero R, La Vecchia C. Cervical cancer screening in Europe: what next?[J].EJC, 2000, 36: 2272-2275.
7Van Ballegooijen M, Van den Akker-van Marie E, Patnick J, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and cost-effectiveness[J]. EJC, 2000, 36: 2177-2188.
8Vizcaino AP, Moreno V, Bosch FX, et al. International trends in the incidence of cervical cancer:I.Adenocarcinoma and adenosquamous cell carcinomas[J]. Int J Cancer,1998, 75: 536-545,.
9Levi F, Lucchini F, Negri E, et al. Cervical cancer mortality in young women in Europe: patterns and trends[J]. EJC, 2000, 36: 2266-2271.
